BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33066779)

  • 1. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
    Jia R; Li Z; Liang W; Ji Y; Weng Y; Liang Y; Ning P
    World J Surg Oncol; 2020 Oct; 18(1):268. PubMed ID: 33066779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.
    Liu Q; Song X; Liu Z; Yu Z
    Technol Cancer Res Treat; 2021; 20():15330338211019506. PubMed ID: 34184566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying breast cancer subtypes associated modules and biomarkers by integrated bioinformatics analysis.
    Wang Y; Li Y; Liu B; Song A
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33313822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 9. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
    Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
    Front Immunol; 2020; 11():560074. PubMed ID: 33304345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3.
    Yang YH; Zhang YX; Gui Y; Liu JB; Sun JJ; Fan H
    World J Gastroenterol; 2019 May; 25(17):2086-2098. PubMed ID: 31114135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
    Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
    Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes in chronic pancreatitis and analysis of association with pancreatic cancer via bioinformatic analysis.
    Li H; Hao C; Yang Q; Gao W; Ma B; Xue D
    Gen Physiol Biophys; 2022 Jan; 41(1):15-30. PubMed ID: 35253647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
    Liu H; Ye H
    Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
    He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
    Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a 15-Gene Signature Model as a Prognostic Tool in Sex Hormone-Dependent Cancers.
    Xia Z; Xiao J; Liu A; Chen Q
    Biomed Res Int; 2021; 2021():3676107. PubMed ID: 34869761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.